Mgr. Kateřina Amruz Černá, Ph.D.
Research specialist, Dáša Bohačiaková Research Group: Neurobiology of the Development and Disease
Correspondence Address:
Kamenice 753/5, 625 00 Brno
Office: bldg. F01B1/1S13a
Kamenice 126/3
625 00 Brno
Phone: | +420 549 49 6989 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 66
2018
-
Bioinformatic analysis of microRNAs and long non-coding RNAs in malignant B cells
Year: 2018, type: Conference abstract
-
CD20 is a direct regulator of B-cell receptor signaling in the microenvironment of chronic lymphocytic leukemia
Year: 2018, type: Conference abstract
-
CD20 reguluje signalizaci přes B-buněčný receptor v mikroprostředí chronické lymfocytární leukémie
Year: 2018, type: Conference abstract
-
CD20 supports BCR signaling in an intra clonal aggressive chronic lymphocytic leukemia subpopulation of cells and rituximab primarily targets these BCR proficient B cells in vivo
Year: 2018, type: Conference abstract
-
Inovativní inhibitor proteinu CHK1 indukuje apoptózu u buněk chronické lymfocytární leukémie s mutacemi v genu TP53
Year: 2018, type: Conference abstract
-
miR-150 downregulation contributes to the high-grade transformation of follicular lymphoma by upregulating FOXP1 levels
Blood, year: 2018, volume: 132, edition: 22, DOI
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma by upregulating FOXP1 levels
Year: 2018, type: Conference abstract
-
MYC-mediated downregulation of miR-150 contributes to the transformation of follicular lymphoma to DLBCL by upregulating FOXP1 levels
Year: 2018, type: Conference abstract
-
p53 limits B cell receptor (BCR) signalling: a new role for miR-34a and FOXP1
Oncotarget, year: 2018, volume: 9, edition: 92, DOI
-
Rituximab primarily targets an intra-clonal BCR signaling proficient CLL subpopulation characterized by high CD20 levels
Leukemia, year: 2018, volume: 32, edition: 9, DOI